RAPT Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RAPT and other ETFs, options, and stocks.

About RAPT

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.

CEO

Brian Russell Wong

CEOBrian Russell Wong

Employees

Employees68

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2015

Founded2015

Employees

Employees68

RAPT Key Statistics

Market cap

156.10M

Market cap156.10M

Price-Earnings ratio

-0.49

Price-Earnings ratio-0.49

Dividend yield

—

Dividend yield—

Average volume

1.29M

Average volume1.29M

High today

$1.20

High today$1.20

Low today

$1.08

Low today$1.08

Open price

$1.09

Open price$1.09

Volume

953.81K

Volume953.81K

52 Week high

$4.01

52 Week high$4.01

52 Week low

$0.7082

52 Week low$0.7082

Analyst ratings

43%

of 7 ratings

Buy

42.9%

Hold

42.9%

Sell

14.3%

People also own

Based on the portfolios of people who own RAPT. This list is generated using Robinhood data, and it’s not a recommendation.